Delivery Order SPE2DB20D2104-SPE2DB25FNAAK
- Not listed
- The Defense Logistics Agency awarded a $2,570.68 delivery order to AmerisourceBergen Drug Corp on August 27, 2025, for the supply of Rifampin 300 mg capsules (60 count). This is a firm fixed-price, competitively awarded contract with no set-aside designation and an ultimate completion date of August 28, 2025. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 25, 2025, for the supply of Rifampin 300 mg capsules (60-count units) with a ceiling value of $8,102.57. This is a firm fixed-price delivery order with an ultimate completion date of July 28, 2025, and represents a non-competitive set-aside procurement. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 11, 2025, for the supply of Rifampin 300 mg capsules (60-count units) with a ceiling value of $3,336.50. This is a firm fixed price delivery order with no set-aside designation, meaning the award was competitively awarded. The ultimate completion date is September 12, 2025, and performance will take place at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery...
- The Defense Logistics Agency awarded a delivery order valued at $1,721.80 to AmerisourceBergen Drug Corp for the supply of Rifampin 300 mg capsules (30-count packaging) on August 20, 2025, with a completion date of August 21, 2025. This is a firm fixed price delivery order with no set-aside designation, indicating it was competitively awarded. The product will be delivered to the Conshohocken, Pennsylvania location, which serves as AmerisourceBergen's corporate headquarters and primary...
- The Defense Logistics Agency awarded a $24.7K delivery order to AmerisourceBergen Drug Corp on September 8, 2025, for the supply of Rifampin 300 mg capsules (60-count units). This competitively awarded, firm fixed-price contract with no set-aside designation is scheduled for completion by September 9, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. Rifampin is a critical antibiotic used primarily for treating tuberculosis and certain other...
- The Defense Logistics Agency awarded a delivery order valued at $5,984.18 to AmerisourceBergen Drug Corp on July 30, 2025, for the supply of Rifampin 300 mg capsules in quantities of 60 units. The contract is a firm fixed price delivery order with an ultimate completion date of July 31, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. This award was made through open competition with no set-aside designation. This delivery order is a child contract issued...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 15, 2025, for the supply of Rifampin 300 mg capsules in unit dose packages of 100 units. This competitively awarded contract, valued at $2,276.64 with firm fixed pricing, represents a child delivery order under AmerisourceBergen's larger pharmaceutical supply agreement with DLA. The order is scheduled for completion by August 18, 2025, with fulfillment performed at the contractor's facility in...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 28, 2025, for the supply of Rifampin 150 mg capsules in quantities of 30 units. This firm fixed-price delivery order, valued at $4,363.44, is non-set-aside and represents a competitive award under the company's existing Indefinite Delivery Contract with DLA Troop Support Medical. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 2, 2025, for the supply of Rifampin 150 mg capsules in quantities of 30 units, with a contract ceiling value of $2,001.28 and an ultimate completion date of September 3, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and is being performed at the awardee's corporate office location in Conshohocken, Pennsylvania. Rifampin is a critical antibiotic...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Rifampin 300 mg capsules (60-count units) under a firm fixed-price contract with a ceiling value of $3,733.05. The award, issued on August 5, 2025, with an ultimate completion date of August 6, 2025, represents a non-set-aside competitive procurement. Performance of this delivery order will take place at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This...
- SPE2DB20D2104Indefinite Delivery Contract
- SPE2DB20D2104-SPE2DB25FNAAKDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 10, 2025, for the supply of Rifampin 300 mg capsules (60-count units) with a ceiling value of $1,020.97. This is a firm fixed-price delivery order with no set-aside designation, indicating the award was made through open competition. The order is scheduled for ultimate completion on September 11, 2025, with performance taking place at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. This prime IDC serves as a comprehensive global pharmaceutical support vehicle enabling AmerisourceBergen to supply a wide range of pharmaceutical products and medical supplies to support military healthcare programs worldwide. Rifampin, an antibiotic commonly used to treat tuberculosis and other mycobacterial infections, represents a critical medical commodity within the Defense Health Agency's pharmaceutical procurement requirements. The contract exemplifies AmerisourceBergen's established role as a major federal pharmaceutical distributor capable of fulfilling both routine and specialized medical supply needs for the Department of Defense.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.0k | 9/10/25 |